Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilbert J Burckart

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Clinical Pharmacology and Therapeutics|March 17, 2024
Assessment of Dosing Strategies for Pediatric Drug ProductsZachary L Taylor, Francis G Green, Nayeem Hossain, et al.
Journal of Clinical Pharmacology|June 17, 2004
Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patientsEun Kyung Cho, Duck Jong Han, Song Cheol Kim, et al.
Human Immunology|August 15, 2002
The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patientsHongXia Zheng, Steven Webber, Adriana Zeevi, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|September 21, 2013
Genetics-based pediatric warfarin dosage regimen derived using pharmacometric bridgingMallika Lala, Gilbert J Burckart, Cheryl M Takao, et al.
Journal of Clinical Pharmacology|May 31, 2008
Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadineShanshan Liu, Paul M Beringer, Levita Hidayat, et al.
Journal of Clinical Pharmacology|April 16, 2025
Pediatric Developmental Drug Toxicity: Description of Juvenile Animal Studies in US FDA Prescribing Information and Assessing the Need for New Approach MethodologiesGelareh Abulwerdi, Hillary Nguyen, Sherbet Samuels, et al.
Clinical Pharmacology and Therapeutics|May 24, 2021
Inclusion of Infants and Neonates in Pediatric Orphan Product ApprovalsKyunghun Park, Riddhi Virparia, Dionna J Green, et al.
Intensive Care Medicine|April 17, 2003
Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failureJoseph A Carcillo, Lesley Doughty, Danny Kofos, et al.
Therapeutic Innovation & Regulatory Science|February 5, 2021
Hypothalamic-Pituitary-Adrenal Axis Pediatric Safety Studies Submitted to the FDAJanelle M Burnham, Dionna J Green, Amber Ray, et al.
Clinical Pharmacokinetics|November 14, 2023
Development of a Generic Fetal Physiologically Based Pharmacokinetic Model and Prediction of Human Maternal and Fetal Organ Concentrations of CefuroximeXiaomei I Liu, Dionna J Green, John van den Anker, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Clinical Pharmacology and Therapeutics|March 17, 2024
Assessment of Dosing Strategies for Pediatric Drug ProductsZachary L Taylor, Francis G Green, Nayeem Hossain, et al.
Journal of Clinical Pharmacology|June 17, 2004
Pharmacokinetic study of mycophenolic acid in Korean kidney transplant patientsEun Kyung Cho, Duck Jong Han, Song Cheol Kim, et al.
Human Immunology|August 15, 2002
The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patientsHongXia Zheng, Steven Webber, Adriana Zeevi, et al.
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG|September 21, 2013
Genetics-based pediatric warfarin dosage regimen derived using pharmacometric bridgingMallika Lala, Gilbert J Burckart, Cheryl M Takao, et al.
Journal of Clinical Pharmacology|May 31, 2008
Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadineShanshan Liu, Paul M Beringer, Levita Hidayat, et al.
Journal of Clinical Pharmacology|April 16, 2025
Pediatric Developmental Drug Toxicity: Description of Juvenile Animal Studies in US FDA Prescribing Information and Assessing the Need for New Approach MethodologiesGelareh Abulwerdi, Hillary Nguyen, Sherbet Samuels, et al.
Clinical Pharmacology and Therapeutics|May 24, 2021
Inclusion of Infants and Neonates in Pediatric Orphan Product ApprovalsKyunghun Park, Riddhi Virparia, Dionna J Green, et al.
Intensive Care Medicine|April 17, 2003
Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failureJoseph A Carcillo, Lesley Doughty, Danny Kofos, et al.
Therapeutic Innovation & Regulatory Science|February 5, 2021
Hypothalamic-Pituitary-Adrenal Axis Pediatric Safety Studies Submitted to the FDAJanelle M Burnham, Dionna J Green, Amber Ray, et al.
Clinical Pharmacokinetics|November 14, 2023
Development of a Generic Fetal Physiologically Based Pharmacokinetic Model and Prediction of Human Maternal and Fetal Organ Concentrations of CefuroximeXiaomei I Liu, Dionna J Green, John van den Anker, et al.
Pageof 13